1 / 4

Cardiac Ablation Market Size, Share & Trends Analysis Report and Forecast 2019-2025

The global cardiac ablation market is anticipated to grow at a CAGR of 12% during the forecast period. The key factors contributing to the market growth include the growing geriatric population coupled with the rise in cardiovascular diseases and technological advancement in the field of ablation devices. The measures taken by governments and healthcare reforms in the US are driving the growth of the market. Emerging countries such as India, China, and Mexico have the growth opportunities for vendors that involve in manufacturing and distribution of products in cardiac ablation.

larebomrglobal
Télécharger la présentation

Cardiac Ablation Market Size, Share & Trends Analysis Report and Forecast 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Global Cardiac Ablation Market: Industry Growth, Size, Share and Forecast 2019-2025 Request https://www.omrglobal.com/request-sample/cardiac-ablation-market-size a free sample of our report on Global Cadiac Ablation Market: ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

  2. The global cardiac ablation market is anticipated to grow at a CAGR of 12% during the forecast period. The demand for minimally invasive technologies in cardiology is anticipated to be one of the major factors for the growth of the cardiac ablation market. Many heart procedures that used to be performed through open-heart surgery can now be performed in a minimally invasive way using catheter. It offers patients many benefits with far fewer risks than traditional open surgery. Over the last decade, the demand for the minimally invasive technology has grown heavily. Various benefits offered by the minimally invasive technologies such as less pain and reduction in the hospitalization time span are one of the prime factors that are augmenting the demand for the minimally invasive technologies in the cardiology. A full report of Global Cardiac Ablation Market available at:https://www.omrglobal.com/industry- reports/cardiac-ablation-market-size Microwave ablation is the fastest evolving technology in cardiac ablation industry. It is capable of making larger and deeper lesions than those of radiofrequency or cryoablation. Microwave ablation has been used successfully to treat atrial fibrillation during open-heart surgery. Radiofrequency catheter ablation is limited to the small volume of tissue directly heated by the radiofrequency electrode. Therefore, microwave energy can be an alternative energy source to generate larger lesions. The reason behind this is increased volume of direct tissue heating. The microwave ablation provides a flexible approach for treatment, which includes percutaneous, laparoscopic, and open surgical access. To https://www.omrglobal.com/request-sample/cardiac-ablation-market-size know more information, please request a free report sample Recent Development In January 2019, Abbot announced the FDA approval of its Tacticath contact force ablation catheter, sensor-enabled and new ablation catheter that is designed to support physicians in accurately and effectively treating Atrial Fibrillation. In January 2019, Medtronic PLC signed an agreement to acquire EPIX Therapeutics, Inc., a privately-held medical device company involved in designing and manufacturing a novel, catheter-based, temperature- controlled cardiac ablation system to treat the patients with cardiac arrhythmias, including atrial fibrillation. With this acquisition, the company has expanded its cardiac ablation product line. In October 2017, Boston Scientific Corp. signed an agreement to acquire Apama Medical, a privately held company involved in developing the Apama Radiofrequency Balloon Catheter System for the treatment of atrial fibrillation. This acquisition was aimed at strengthening the company's electrophysiology portfolio and expand into "Single-Shot" balloon pulmonary vein isolation treatments for patients with atrial fibrillation.

  3. Cardiac Ablation Market Segmentation By Technology •Cryo Ablation •Radiofrequency Ablation •Microwave Ablation •Ultrasound Ablation By Application •Cardiac Rhythm Management •Open Surgery Visit here to know more about Global Cardiac Ablation Market Cardiac Ablation Market – Segment by Region North America •US •Canada Europe •Germany •UK •France •Spain •Italy •Rest of Europe Asia-Pacific •China •Japan •India •Rest of Asia-Pacific

  4. Rest of the World •Middle East & Africa •Latin America About Orion Market Research OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404 Source: Cardiac Ablation Market

More Related